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1. Introduction 
Antimicrobial peptides (AMP) are usually described as being short (less than 100 a.a.), gene 
encoded, ribosome synthesized, polypeptide substances that have antimicrobial activity. For 
simplicity reasons, we will exclude peptaibol and other non-ribosomaly synthetized 
antibiotic from our classification. 
The first peptidic antibiotic was described in 1968 coming from the Manduca sexta and was 
of linear nature; since then the number of antimicrobial peptide discovered have grown 
asymptotically. Though loose homology has been found between certain set of antimicrobial 
peptides; it has proven difficult to classify the AMP through their primary structure. 
Antimicrobial peptides show a great diversity of primary structures, and their short size do 
not permit robust evolutionary classification, but for the most close related peptides. The 
primary structures signature of the different AMP families may have arisen independently, 
and in some case these structures homology are the result of convergent evolution rather 
than a common ancestry. Nevertheless in order to classify the new components, general 
classification methods have been established. So far this has been done regardless of 
evolutionary relationship, source or activity. The criteria that have been commonly used are 
the number of disulfide bridges and particular amino-acid composition. In 2005 P. Bullet 
and co-workers suggested a 3 categories classification namely: α-Helical  host defense 
peptides (HDPs), β-Sheet HDPs, Flexible HDPs rich in certain amino acids (Bulet et al., 
1999). Though most AMP would fit in this classification, little insight about function can be 
inferred from the class relation; nor does it give any comparative information between 
peptides belonging to the same class.  
More recently Tomas Ganz proposed a structural classification of the AMP based on their 
secondary structure (Ganz, 2003b). The classes proposed included antimicrobial peptides 
with 4 disulfide bridges with alpha helix and beta sheet mixed structures, 3 disulfide bridges 
with alpha helix and beta sheet mixed structures, 3 disulfide bridges with beta sheet motif, 3 
disulfide bridges with two alpha helix and beta sheet mixed structures, 2 disulfide bridges 
with beta-sheet structures, one disulfide bridge cyclic peptide and alpha helical peptides. 
The classification proposed here contains 9 different peptide structure families. The last group 
consider hybrid structure peptide possessing structural features of more than one AMP class. 
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1.1 The lineal amphipathic alpha-helix antimicrobial peptide 
1.1.1 General properties 
The first peptide of this family discovered is the cecropin A from the pupae of the moth 
Hyalophora cecropiae (Steiner et al., 1981; Hultmark et al., 1982). This structure of AMP has 
been encountered in virtually all the multi-cellular organisms. Even if their sequences show 
some similarity, they are not all evolutionary linked. As such, they cannot be aligned as a 
whole, and are commonly separated in structural subclasses: Cecropin, magainin and 
dermaseptin AMP. This AMP class do share general common features: the lack of cysteine 
bridges, the tendency to form alpha helical secondary structure in relatively hydrophobic 
solvent, the net positive charge at neutral pH and hydrophobic residues interspersed every 
3 amino acid, giving them an amphipatic nature. Indeed, basic amino acid side chains face 
predominantly one side of the alpha helix and hydrophobic residues are generally on the 
other side of the molecule. A global alignment of the linear peptides separates three 
different classes that could be broadly characterised as Dermaseptin, magainin and cecropin 
class of lineal amphipathic AMP. Most of these peptides share the present a glycine near the 
middle of their peptidic sequence.  
1.1.2 Dermaseptins peptides 
These peptides were extracted from Phyllomedusa genus frog skin secretions. Some of them 
present a proline-induced kink in the middle of the alpha helix (Shin et al., 2001). Others 
have a glycine in the same relative position that has been suggested to give the flexibility 
needed for the membrane lysis activity (Xiao et al., 2006).  This structural plasticity has been 
defined as a molecular determinant for the antimicrobial vs eucaryont membrane specificity 
(Shin et al., 1999; Shin et al., 2000; Shin et al., 2001), together with overall net positive charge 
and hydrophibic moment. They present hydrophobic and positively charged amino acid in 
an alternate pattern. Though mature dermaseptin amino acid sequences are highly variable, 
their acidic pro-peptides are strikingly conserved (Azevedo Calderon et al., 2010). 
1.1.3 Cecropin peptides 
Cecropin peptides were first purified from insect hemolymph, and their expression is 
usually inducible. Cecropins structural conformations were determined by NMR. Circular 
dichroism and NMR (Nuclear Magnetic Resonance) data have shown that in aqueous 
solvent the cecropin structure is largely disordered; but they adopt a stable alpha-helical 
secondary structure in more hydrophobic environment. This makes the insertion of these 
peptides in the lipidic membranes entropically favorable. Cecropin usually present a glycine 
in the middle of their amino acid sequence. This glycine has been proposed to induce a kink 
between the alpha helical structures that these peptides form in hydrophobic solvent. In 
turn the deletion of this glycine or its replacement by another amino acid do not eliminate 
the antimicrobial activity; instead it endows these mutant peptides with hemolytic and 
cytolytic activity (Moore et al., 1996). The cecropin usually present a tryptophan in one of 
the first two amino acid position as well as a glycine in the first position. 
1.1.4 Magainin/scorpions AMP/cathelicidin peptides 
Magainin peptides come from the frog genus Xenopus (Duclohier et al., 1989). In this AMP 
class arthtropod AMP like Opistoporin-2 from Scorpion Opistophthalmus carinatus are also 
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included (Moerman et al., 2002) as well as cathelicidin peptides (Travis et al., 2000) and the 
fly cecropin from Stomoxys calcitrans (Boulanger et al., 2002). This phylogenetically 
heterogeneous group present lysine/argine doublet repeats that could be considered as a 
structural signature. These peptides do not present the conserved glycine present in the 
other 2 lineal amphipatic AMP subclasses. Their positive general formal charge at neutral 
pH is higher than the one of the cecropin and dermaseptin AMP. They also present a 
conserved aspartic acid residue at the amino side of these peptides. 
1.2 Proline rich peptides 
This AMP class has been first described in mammals, in the intestine of Sus scrofa, 
(Agerberth et al., 1991). They are also present in Hymenoptera, Lepidoptera and diptera. 
Some of these peptides from this AMP class have been studied extensively, like drosocin 
from D. melanogaster (Bulet et al., 1993), pyrrhocoricin from the European sap- sucking bug 
Pyrrhocoris apterus (Cociancich et al., 1994) apidaecins from the Apis mellifera (Casteels-Josson 
et al., 1993), and formaecin from the ant Myrmecia gulosa (Mackintosh et al., 1998). Mature 
proline-rich antimicrobial peptides vary in length from 12 to 54 amino acid, and have few 
common structural feature. Some authors distinguish between glycine/proline rich and 
alanine/proline rich peptides. The variety of sequence does not allow for straightforward 
sequence signature recognition for these peptides. Therefore, their antibacterial 
activity/specificity is not deducible from the sequence analysis. 
On the other hand, some of these peptides are able to penetrate the microbial cytoplasm 
without inducing bacterial lysis, and do not present hemolytic or cytolitic activities 
(Knappe et al., 2010). Model PR peptides have been designed, using the Ac-(Arg-Pro-Pro-
Phe)n-NHCH3 framework, and some essential structural feature, necessary for 
antimicrobial activity have been determined. The ability to form poly(proline)-II structure 
in aqueous solution, as well as a critical peptide length are essential for antimicrobial 
activity (Niidome et al., 1998).  
1.3 Glycine/arginine rich peptides 
The first purification of glycine rich peptide was done in 1991 (Bulet et al., 1991). As for the 
proline rich antimicrobial peptide class, the glycine rich peptides have variable sizes and do 
not show clear sequence signature, apart from the high proportion of glycine in their 
primary sequence. These peptides are in general longer than AMP from other classes.  
Between 25 to 50% of their amino acid are glycines. They have disordered structure in water, 
and tend to self-order when in contact with artificial membranes (Bruston et al., 2007). The 
structure of bombinin H resembles the influenza hemagglutinin fusion peptide (Zangger et 
al., 2008). When binding to DPC micelles, a helix is formed that have a glycine ridge on one 
side. There is an helix-helix interaction that leads to a multimerization process in the 
bacterial membrane (Zangger et al., 2008). 
1.4 Brevinin (hook structure) peptides 
This class of peptides is characterized by having a short amino acid sequence, and a 
carboxyloterminus disulfide bridge. Some brevinin peptides show post-translational 
modification. The amino acids included in the carboxyloterminus loop are determinant for 
the specificity of the antimicrobial activity as well as the length of the loop (Lee et al., 2002) . 
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The brevinin show alpha helical structure in sodium dodecyl sulfate solution (Lee et al., 
2002). Antibacterial activity is favored by structure that group the cationic amino acids of 
the molecule with on one side an hydrophobic stretch of amino acids and on the other side 
streches of apolar amino acids (Kumari and Nagaraj, 2001). Liposome disruption activity of 
the brevinins correlates with the anti-Gram positive bacterial activity, suggesting a lytic 
activity. None of the peptides showed hemolytic activity making brevinins attractive 
prospects for broad-spectrum antimicrobial peptide design (Lee et al., 2002). 
1.5 Defensins (cysteine knot structure) 
1.5.1 General properties 
This class of peptide is characterized by its rigid structure, given by the presence of 3 to 4 
disulfid bridges. They are sub-classified through their cysteines connectivity and their 
secondary structure.  
By virtue of the cysteine knot motif that stabilize them, all these peptides show a rigid 
secondary structure. Defensin are amphipatic molecules with a common defined beta sheet 
motif secondary structure. Indeed there is a gamma-core motif (GXCX(3-9)C), considered 
the structural signature of the disulfide-stabilized antimicrobial peptides that present two 
beta strands with an interposed loop (Sagaram et al., 2011). This motif has one hydrophobic 
and one hydrophilic side. The hydrophilic side of these peptides is usually constituted by 
several lysine or arginine aminoacids. This gives them a general positive charge at 
physiological pH. They are resistant to degradation and peptidase digestion because of their 
compact structure. As for the other antimicrobial peptide classes, there are few phylogenetic 
relationships even within each defensin subclass. The first three defensins class described 
were found exclusively in mammals. 
1.5.2 Alpha defensins 
This type of defensins is found in mammals. Their cysteine are connected between the 
cysteines 1-6 2-4 3-5. They show a structure of triple-stranded beta-sheet stabilized by a 
conserved triple disulfide bridges array (Hadjicharalambous et al., 2008). Alpha defensin 
sequence present more arginine than lysine residues, and it has been suggested that this 
high arginine content endows the alpha-defensin with a higher antibacterial activity in high 
salt conditions (Llenado et al., 2009).  
P. hamadryas alpha-defensin ACYCRIPACFAGERRYGTCFYLGRVWAFCC 
1.5.3 Beta defensins 
The beta defensin have a cysteine connectivity of 1-5 2-4 3-6. They present the consensus 
sequence of Xn-C-X2-4-G-X1-2-CX3-5CX9-10CX5-6CCXn (Ganz, 2003a) (C=cysteine and 
G=Glycine). They present a tri dimensional structure of a triple stranded beta sheet.  The 
glycine invariant is also present in alpha defensin. This glycine is necessary for the beta 
bulge structure to be formed, and the protein is unable to fold if it is replaced by any other 
natural amino acid (Xie et al., 2005). 
Sus scrofa beta-defensin 1  SVSCLRNKGVCMPGKCAPKMKQIGTCGMPQVKCCKRK 
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1.5.4 θ defensins 
θ defensin are macrocyclic octadeca peptides connected head to tail. These peptides are 
present in monkeys but absent in human. There are θ-defensin ortholog pseudo genes in the 
human genome but the Theta-defensin genes contain a premature stop codon that aborts 
translation. (Cole et al., 2002) (Cole et al., 2004). Their synthesis implies a head to tail 
circularization of an octa-peptide (Selsted, 2004). They were found to be active  against S. 
aureus, E. coli, and C. albicans as well as HIV virus (Cole et al., 2002). This type of defensins 
also present a disulfide bridges stabilized amphipathic beta sheet structure.  
P. hamadryas theta-defensin-1  RCVCRRGVCRCVCTRGFC 
1.5.5 Insect defensins 
The insect defensin class have an alpha-helix secondary structure bound to the beta sheet. 
Their structures are similar to another arthropod peptide class: the scorpion potassium 
channel blocker toxins (Bontems et al., 1991). Study of the structural features involved in the 
antimicrobial activity of longicin, a defensin from the hard tick Haemaphysalis longicornis, 
showed that the beta sheet alone was sufficient for antimicrobial activity. This part of the 
insect peptide is positively charged at neutral pH, as does the alpha helix of the same, 
nevertheless the role of the alpha-helix, at the antimicrobial level, seems to be restricted to 
maintain the globular shape of the peptide (Rahman et al., 2009).  
R. prolixus insect defensin B 
ATCDLLSFRSKWVTPNHAGCAAHCLLRGNRGGHCKGTICHCRK 
1.5.6 Plant defensins 
Plant defensin antimicrobial peptide class present 4 disulfide bridges with a cysteine 
connectivity of 1-8, 2-5, 3-6, and 4-7. Their three-dimensional structures are similar to the 
insect defensin structure in that they have a disulfide bonds stabilized alpha-helix.  Their 
structure also show a triple anti-parallel beta-strands. (Sagaram et al., 2011). The strong 
antifungal activity of the plant defensin has been associated with their alpha helix motif, in a 
similar fashion as for insect defensin  (Lamberty et al., 2001). Conversely, heliomycin, a 
defensin from Heliothis virescens, has more structural communality with plant defensin than 
with insect defensin (Lamberty et al., 2001). 
P. sylvestris defensin 1  
RMCKTPSGKFKGYCVNNTNCKNVCRTEGFPTGSCDFHVAGRKCYCYKPCP 
1.6 Tachyplesin 
This class of AMP was first found in horseshoe crab (Polyphemus litoralis). Gomesin is a 
tachyplesin type of antimicrobial peptide found in tarantula hemocyte (Silva et al., 2000); 
and androctonin has been extracted from scorpion hemolymph (Mandard et al., 1999). This 
type of antimicrobial structure is broadly distributed amongst the genus. The AMP related 
to this class of peptide present a beta sheet secondary structure stabilized by two disulfide 
bridges (Nakamura et al., 1988). Tachyplesin have a rigid conformation of antiparallel beta-
sheet connected by a beta-turn (Iwanaga et al., 1994). The tachyplesin family of AMP adopts 
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beta-hairpin-like structures when in contact with hydrophobic solvent. NMR studies 
revealed a largely unordered structure in water, but a transition to a regular beta-hairpin 
backbone conformation in the presence of dodecylphosphocholine micelles. The cysteine 
null mutant of protegrin, a mammal tachyplesin type peptide, revealed that the cystein 
bridges were not necessary for antimicrobial activity. Aside from their antimicrobial 
activity, tachyplesin have also a scavenger capability. They bind lipo-polysacharide with 
high affinity (Niwa et al., 1990). The structure of tachyplesin I also interacts with Vesicular 
stomatitis virus envelope, inactivating the virus (Murakami et al., 1991).  
Tachyplesin III Tachypleus gigas: KWCFRVCYRGICYRKCR 
1.7 Tryptophan rich antimicrobial peptides 
The archetypical W rich peptide is the indolicin, this peptide comes from Bos Taurus 
neutrophils and is the result of proteolysis. Unlike the amphipathic alpha helical structure of 
the cecropin class of peptides, their linear structure (no disulfid bridges) has no particular 
secondary structure in water. Indolicin is globular and amphipathic in aqueous solution, 
while it adopts a wedge shape when in contact with micelles. Indolicin  shows a high 
affinity for neutral POPC and anionic POPG vesicles(Hsu et al., 2005). The author suggests 
that the structure changes and the strong membrane affinity are key to the antimicrobial 
activity of indolicin (Ladokhin and White, 2001). Tryptophan rich AMP contains more than 
25% of the aminoacid. Indolicin, the archetypical tryptophan rich antimicrobial peptide, has 
a globular secondary structure in water, but show a wedge shape when in contact with in 
lipid micelles (Rozek et al., 2000). This peptide has the ability to permeate bacterial 
membranes and, depending of its tridimensional shape, inhibits DNA synthesis by binding 
to it (Hsu et al., 2005).   
Indolicin: H-ILPWKWPWWPWRR-NH2 
1.8 Histidine rich glycoprotein peptides 
Histidine-rich amphipathic cationic peptides are peptides with ¼ of their amino acids 
represented by histidine. They show a global cationic amphipathic helical structure. They 
trigger microorganism membrane disruption when the peptide adopts an alignment parallel 
to the membrane surface. Even though, pore formation is not essential for their high 
antimicrobial activity (Mason et al., 2009). Clavinin and daptomycin are other studied 
members of this antimicrobial peptide class. Some Histine rich peptide, like LH4, also have 
the capability to enhance transfection, a feature that is related to membrane perturbation 
capability (Georgescu et al., 2010).  
1.9 Mixed structure peptides  
Some peptides share structural communality with more than one class of AMP; the sum of 
the different AMP part activity are not additive; and these peptides classes do show unique 
activity not present in the separated structural part of the molecule. Scorpine type AMP 
represent a class on its own, as several homologous proteins have been found. The 
structural defensin part of the molecule resembles the insect peptides. It has been 
determined in later studies that once separated from the linear cecropin-like amino 
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terminus, this peptide could effectively block these channels. Even though, the antimicrobial 
activity of the complete molecule was dependent of the presence of this toxin/defensin 
motif (Diego-Garcia et al., 2008).   
The penaeidin class of peptide consist in proline-rich N-terminus and of a C-terminus 
containing six cysteine residues engaged in three disulfide bridges (Destoumieux et al., 
2000). The proline-rich domain of penaeidin class AMP suffices to confer target specificity 
and antimicrobial activity of penaeidin (Cuthbertson et al., 2004). The carboxyl end cysteine-
rich domain consists of an amphipathic helix linked to the upstream and the downstream 
coils by two disulfide bonds. The peptide shows a highly hydrophobic core of globular and 
compact structure, that has 2 arginines exposed on each side (Yang et al., 2003). 
Another example of hybrid antimicrobial peptide is Hyastatin, isolated from the spider crab 
(Hyas araneus) hemocytes (Cuthbertson et al., 2008). This AMP combines a Glycine rich motif  
N-terminal region, a short Pro/Arg-rich region, and a panaeidin like C-terminal region 
containing 3 disulfid bridges (Sperstad et al., 2009). 
The chicken beta defensin 11 is formed by the repeat of two defensin motif, therefore having 6 
disulfid bridges. This defensin show a nanomolar range of anti E.coli activity, being one of the 
most effective antimicrobial peptide for this microorganism (Herve-Grepinet et al., 2010). 
Microplusin, is a Rhipicephalus (Boophilus) microplus anti-microbial peptide (AMP). 
Microplusin has a cysteine-rich AMPs structure with histidine-rich regions at the N- and C-
termini. Microplusin consists of five alpha-helix and has been shown to bind copper and 
iron (Silva et al., 2009). 
2. Antimicrobial mechanisms of AMP 
The activity of AMPs must start at the cytoplasmic membrane since most AMPs permeabilize 
microbial membranes. Several models have been proposed on how AMPs insert into the 
membrane leading to the formation of ion channels, transmembrane pores or extensive 
membrane rupture. These models are: 1) transmembrane pore models and 2) nonpore models 
activity. Here we will also review other antimicrobial mechanisms that have been found. For 
example, the antimicrobial mechanisms of apidaecin do not rely on pore forming activity, this 
peptide does have antimicrobial activity at a concentration at least four order of magnitude 
below the concentration that disturbs the bacterial membrane. Peptides from each structural 
family have been reported to rely on antimicrobial mechanism that would not imply 
membrane depolarization of the target microorganism, suggesting internal molecular 
determinant. Certain peptides are unable to cause membrane depolarization at the minimal 
inhibitory concentration, while other cause maximal depolarization well below the MIC 
(Minimal Inhibitory Concentration) value. Evidences are mounting that involve particular 
macromolecules as well as intracellular functions as the final target for antimicrobial activity 
of the AMP. Even though, bacterial membranes are a necessary entry path for the AMP, 
therefore determining part of the AMP selectivity as well as efficiency.  
2.1 Transmembrane pore models of AMPs 
There are more than 1,000 known AMPs (Brahmachary et al., 2004; Wang and Wang, 2004; 
Fjell et al., 2007), and for the majority of them, there is little or no evidence for 
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transmembrane pores (Wimley, 2010). Instead, there is compelling evidence that many 
AMPs function by binding to membrane surfaces and disrupting the packing and 
organization of the lipids in a nonspecific way. The simplest models of membrane 
permeation by peptides involve the formation of membrane-spanning pores. These pores 
have been studied in lipid bilayers and have been proposed to be the major cause of 
bacterial membrane depolarization. As bacteria ATP synthesis is linked to the trans-
membranal potential of the cell, any perturbation of the ion partition may potentially lead to 
the cell death. The structure of these peptides induced pores have been analyzed and several 
pore structure were proposed. 
The barrel stave pore model (Rapaport and Shai, 1991) involves a mechanism where the 
peptides interact laterally with one another to form a specific structure enclosing a water-
filled channel, much like a protein ion channel.  Bioinformatic analysis of protegrin 1 
insertion in membranes concluded that this model was most consistant with the observed 
energy of insertion of the peptide in artificial membranes (Langham et al., 2008). 
Furthermore the electrophysiology record analysis of Ceratotoxin and pleuricidin peptides 
inserted in lipid bilayers show that they form a peptide filled pore isolated from the lipids 
from the membranes. The pore formation dynamics correlates with their antimicrobial 
activity (Bessin, 2004). 
In the toroidal pore model (Ludtke et al., 1996), specific peptide–peptide interactions are not 
present  Instead, the peptides affect cooperatively the local curvature of the membrane, 
forming a peptide lipid toroid pore in the membrane. The cathelicidin peptide LL 37 (an 
amphipathic, alpha-helical, antimicrobial peptide) appears to form such kind of pore in the 
microbial membranes. NMR spectra studies of LL 37 shows that its pore channel is filled 
with the membrane lipids phosphate heads. The resulting ionic leakage ultimately leads to 
bacterial membrane depolarization (Henzler Wildman et al., 2003). The pore formation of 
cateslytin, a beta sheet conformation peptide, has been studied through patch clamp and 
NMR experiments, and has been found to fit a pore formation model involving transient 
dissymmetry between the phospholipid leafs of the membrane as a key ingredient to 
explain the formation of the pore (Jean-Francois et al., 2008)  
The carpet model for AMP antimicrobial activity , originally described by Shai (Gazit et al., 
1996), is the most commonly cited model of membrane destabilization by AMPs. The 
carpet/detergent model proposes that the accumulation of the peptides imbedded in the 
microbial membrane provoques perturbation in the membrane integrity. Antimicrobial 
peptides accumulate on the membrane surface with an orientation that is parallel to the 
membrane untill peptide concentration has reached a critical level (i.e., a peptide-rich 
‘‘carpet’’ has formed on the membrane surface). Then permeabilization occurs, via global 
bilayer destabilization. PMAP-23, a cationic peptide member of the cathelicidin family, is 
considered to induce membrane permeability according to the Shai-Matsuzaki-Huang 
"carpet" model (Bocchinfuso et al., 2009). Cecropin P1, another alpha helical AMP, 
imbedded in reconstituted phospholipid bilayer is preferentially oriented nearly parallel to 
the surface of the lipid membranes, a position that is incompatible with the proteinaceous 
pore model, as demonstrated by polarized ATR-FTIR spectroscopy analysis(Gazit et al., 
1996) The detergent model is also often cited to explain the catastrophic collapse of 
membrane integrity, observed with some AMPs at high peptide concentration (Ostolaza et 
al., 1993; Hristova et al., 1997; Bechinger and Lohner, 2006). Some authors combine the 
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carpet and detergent models into a single idea in which the catastrophic collapse of 
membrane integrity includes membrane fragmentation. Others distinguish between the two 
models based on whether or not the peptide-induced leakage efficiency depends on the size 
of the entrapped solutes (Ostolaza et al., 1993). Bechinger and Lohner (Bechinger and 
Lohner, 2006; Salnikov et al., 2009) recently discussed molecular shape models in which 
AMP lipid interactions could be depicted with phase diagrams to describe the propensity of 
an AMP to permeabilize a membrane by disrupting the lipid packing. Epand and colleagues 
have proposed a lipid clustering model in which AMPs induce clustering or phase 
separation of lipids, with leakage occurring due to boundary defects (Epand et al., 2009; 
Epand et al., 2010). Almeida and colleagues have described AMP activity in terms of 
binding, insertion and perturbation using the sinking raft model, which they recently 
augmented by adding a formal thermodynamic analysis to predict activity (Pokorny and 
Almeida, 2004; Gregory et al., 2008; Almeida and Pokorny, 2009; Gregory et al., 2009; 
Almeida and Pokorny, 2010). Interfacial activity is defined as the propensity of an 
imperfectly amphipathic peptide to partition into the bilayer interface and drive the vertical 
rearrangement of the lipid polar and non polar groups. The disruption of the normally strict 
segregation of polar and nonpolar groups causes membrane permeabilization.  
While these models, and others, have been useful in discussing AMPs, the molecular 
organization of the lipid bilayer undergoing solutes leakage in the presence of AMPs is still 
very much unknown. Without this knowledge, it remains challenging to predict structure–
sequence activity relationships; thus, it also remains challenging to engineer or de novo 
design AMPs.  
2.2 Non membrane mediated models of AMP activity 
In addition to the pore models described above, AMP activity has been described using 
antimicrobial mechanism that do not involve bacterial membrane permeability 
impairement. For instance PR-39, a porcine proline-arginine-rich antibacterial peptide was 
found to lyse the microbes through a non pore forming mechanism, altering the microbe 
division and septum formation (Shi et al., 1996). Small Anionic antimicrobial peptides have 
been found in ovine lungs, that appear to  function without the need for the initial 
electrostatic interaction with the bacterial membranes, and kill the bacteria through 
intracellular content flocculation (Brogden et al., 1998). Mersacindin, a lantibiotic, has been 
shown to inhibits bacterial cell wall formation (Brotz et al., 1997). Some antimicrobial 
peptides like the pleurocidin and dermaseptin inhibit bacterial DNA synthesis while buforin 
II and tachyplesin bind to nucleic acid in general (Yonezawa et al., 1992). The proline rich 
AMP family target proteicious or nucleic acid intracellular molecules (Park et al., 2008), 
indeed members of the proline-rich AMP family like Drosocin, pyrrhocoricin, and apidaecin 
have been shown to act on bacterial  GRO EL and Dna K proteins(Otvos et al., 2000). 
3. AMP classical functions  
The classical function of AMP has been their role as major effectors of the innate immune 
system; AMPs complement the highly specific but relatively slow adaptive immune system. 
Unlike the acquired immune mechanisms, endogenous AMPs, which are constitutively 
expressed or induced, provide fast and effective means of defense. Most of these gene-
encoded peptides are mobilized shortly after microbial infection and act rapidly to 
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neutralize a broad range of microbes (bacteria, virus and protozoa). The ubiquitous nature 
of antimicrobial peptides suggests that their role in nature has been long standing and must 
have contributed to an organism’s fitness. Many of these molecules exert mechanisms of 
action that appear to be unique and highly complex. However, AMPs exhibit varying, and 
in some cases, significant degrees of host cytotoxicity, reflecting non-selective cell targeting 
(Shin et al., 1999). It is likely that distinct antimicrobial peptides have evolved to function 
within specific physiologic and anatomic contexts to minimize their potential to 
concomitantly injuring the host cells. An intensive area of focus regarding antimicrobial 
peptide biochemistry relates to the precise mechanisms by which these molecules cause cell 
death. A long-held paradigm for microbicidal action has been that AMPs kill 
microorganisms by initiating multiple injuries in target microbial cell membranes. The 
principal theory suggest that peptides may create membrane pores in the organism, making 
a leakage of some metabolites, ensuing depolarization, loss of membrane-coupled 
respiration and biopolymer synthesis, and ultimately cell death. However, other authors 
suggest additional mechanisms, , where membrane permeabilization alone appears to be 
insufficient to cause cell death. These evidences come from studies documenting a clear 
dissociation between membrane perturbation and cell death. In these cases, cell killing may 
proceed in the absence of significant disruption in membrane architecture, due rather to 
disruptions in cellular function (Zhang et al., 2000). The functional integrity of the 
cytoplasmic membrane is crucial to essential functions of microbial pathogens, including 
gradient formation and selective permeability, cellular energetics, and synthesis of bio-
molecules (Yeaman et al., 1998). 
The general membrane effects of AMP are the membrane perturbation however alone may 
be insufficient for microbicidal effects of certain peptides. Permeabilization alone does not 
invariably result in staphylococcal death due antimicrobial peptides. Different peptides with 
varying staphylocidal potencies exhibited disparate capacities of membrane 
permeabilization and cell killing (Koo et al., 2001). Similar studies showed that gramicidin S 
rapidly depolarizes Pseudomonas aeruginosa, but did not kill it, suggesting that the concept of 
membrane perturbation and eventual cell killing may be independent (Zhang et al., 2000). 
Bacterial membrane energetic also appears to be involved in AMP mechanisms of action 
(Yeaman et al., 1998). It is now widely recognized that the AMP concept could play a 
promising role in fighting the presently raging microbial resistance to conventional 
antibiotics. 
4. Unconventional function of AMP 
4.1 Regulatory activities of AMPs. 
Besides the role of endogenous antibiotics, the antimicrobial peptides have other functions 
in the inflammation; wound healing and regulation of the response immune response, of 
which are described below. 
Microbial infection of the mucosa and skin induces production of large quantities of small 
antimicrobial peptides, including defensins and cathelicidins, (Zasloff, 2002; Ganz, 2003a; 
Yang et al., 2004). They can act as chemokines, such as some β-defensins chemoattract 
immature iDC and other effector cells through the CCR6 receptor (Biragyn et al., 2002); 
(Niyonsaba et al., 2004) or human cathelicidin LL-37 recruits neutrophils, monocytes and 
mast cells via human formyl peptide receptor-like 1, FPRL1 (De et al., 2000)  (Agerberth et 
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al., 2000; Niyonsaba et al., 2002). Defensins can also activate effector cells that can work 
together with the complement system to destroy microbial invaders. The α-defensins 
HNP1~3 have been reported to increase the production of TNFa and IL-1 while decreasing 
the production of IL-10 by monocytes (De et al., 2000). Some α-defensins enhance expression 
of adhesion molecules including ICAM-1, CD11b, and CD11c by neutrophils and facilitate 
the recruitment and enhance the microbicidal activity (Van Wetering et al., 1997; Chaly et 
al., 2000; Di Nardo et al., 2003) (FÈger et al., 2002). β-defensins induce mast cell 
degranulation and release of histamine and prostaglandin D2 (Yamashita and Saito, 1989; 
Befus et al., 1999; Niyonsaba et al., 2001) increase the expression of CXCL8 and CXCL5 (Van 
Wetering et al., 1997; van Wetering et al., 2002). Furthermore, murine β-defensin 2 has been 
shown to act directly on immature DCs as an endogeneous ligand for Toll like receptor 4 
(TLR-4), inducing up regulation of co-stimulatory molecules and DC maturation, triggering 
robust, Th1 polarized adaptive immune responses in vivo (Biragyn et al., 2002). However, 
the mechanisms that regulate these functions are not well studied. Defensins attract 
inflammatory cells as neutrophils, B lymphocytes and macrophages. All these cells release 
inflammatory mediators such as IL-8, IFNγ, IL-6, IL-10 and LTB4. It is interesting that 
defensins may also have anti-inflammatory activity by the induction of IL-10 or SLPI.(Durr 
and Peschel, 2002; Zasloff, 2002).The synthesis of β-defensins by epithelial cells and the 
recruitment of peripheral blood granulocytes α-defensin-rich site of inflammation generates 
a high concentration of them. Also have direct antimicrobial effects, defensins facilitate and 
amplify the subsequent immune response. Indeed, spleen cells stimulated with α-defensins 
increase the production of human cytokines and lymphocyte proliferation. This same type 
of defensins, when administered to mice, produces increased serum IgG1, IgG2 and IgG2b. 
In addition, small amounts of HNP extend the antibody response against a singenic tumor 
(Tani et al., 2000). 
These results indicate, without doubt, the AMPs have a role in the regulation of the 
immune response. On the other hand, recent studies have identified several structurally 
diverse endogenous mediators of innate immunity with certain features: firstly, they are 
rapidly released in response to infection or tissue injury; secondly, they have both 
chemotactic and activating effects on APCs; and thirdly, they exhibit particularly potent in 
vivo immunoenhancing activity and enhance DC differentiation from DC precursors. This 
subset of mediators alerts host defenses by augmenting innate and adaptive immune 
responses to tissue injury and/or infection. On the basis of their unique activities, they are 
called ‘alarmins’ (Oppenheim and Yang, 2005). Innate-immune mediators possessing 
alarmin activity include defensins, cathelicidin, eosinophil-derived neurotoxin (EDN), 
and high mobility group box protein 1 (HMGB1) (Oppenheim and Yang, 2005). The 
concept of alarmins is very interesting. This has only been observed in mammals, but is 
likely to exist in other groups of animals including insects. It has been observed over-
expression of antimicrobial peptides during infection with various pathogens and even 
damage to the cuticle. Many groups of insects have been used to understand the basic 
characteristics of the innate immunity. However, surprisingly, the study of AMPs in 
insects has been limited study of their bactericidal or antiparasitic activity and virtually 
no information on the alternative role that could have the AMPs on the immune response 
in these organisms. 
Differential analyses after bacterial or fungal challenge showed the regulation of more than 
a 100 molecules in adult Drosophila hemolymph (Levy et al., 2004). Using differential 
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MALDI-TOF MS, 28 peptides with a molecular mass below 15 kDa and belonging to 
different structural families were identified and could be classified into two groups. The first 
group contains the AMPs and their different isoforms. DIMs belonging to this group are 
likely to be effectors molecules of the immune response through their antimicrobial activity. 
The second group contains molecules for which the lack of similarity to any peptide 
prevents the proposition of any precise function. These peptides are suspected to serve as 
chemokines during the Drosophila immune response but the different approaches for 
investigating their role have so far been unsuccessful (Levy et al., 2004). On the other hand, 
our group has analyzed the peptides in the hemolymph of mosquitoes An. albimanus 
infected with malaria parasites. We found a complex pattern of peptides, including 
cecropin, which are released into the hemolymph. Similarly, gambicin, cecropin, and 
defensin are over-expressed in the intestinal epithelium and fat body of mosquitoes infected 
with Plasmodium. However, it is unknown whether these peptides participate in the 
elimination of the parasite. Cecropin has been consider an important AMP against 
Plasmodium, but in vitro assays with synthetic cecropin did not affect Plasmodium viability 
(unpublished results), but this peptide is over-expressed in mosquitoes infected with the 
parasite (Herrera-Ortiz, A. et al., 2010.). It would be interesting to analyze the peptides 
released into the hemolymph of these insects and their role in regulating the immune 
response.  
4.2 Anti-inflammatory (Anti-endotoxin) roles of host defense peptides 
Bacterial lipopolysaccharides (LPS), also known as endotoxins, are major structural 
components of the outer membrane of Gram-negative bacteria that serve as a barrier and 
protective shield between them and their surrounding environment. LPS is considered to be 
a major virulence factor as it strongly stimulates the secretion of pro-inflammatory cytokines 
which mediate the host immune response and culminating in septic shock. 
Early experiments determined that a number of host defense peptides from various sources 
bound to LPS from diverse Gram-negative bacteria and reduced LPS-induced release of pro-
inflammatory cytokines (e.g. TNF-α, IL-1, IL-6) and nitric oxide from monocyte or 
macrophages and protected mice from LPS lethality (Larrick et al., 1994; Larrick et al., 1995; 
VanderMeer et al., 1995; Kirikae et al., 1998). Initial studies focused on the unprocessed form 
of cathelicidin, hCAP- 18 (Kirikae et al., 1998); however, it was later found that the LPS-
binding properties of the peptide were contained within the processed 37-amino acid C-
terminal domain, LL-37 (Turner et al., 1998). It has been proposed that the anti-endotoxic 
properties of these peptides are the result of the inhibition of binding of LPS to CD14 
(Nagaoka et al., 2001) and lipopolysaccharide binding protein (LBP) (Scott et al., 2000), 
and/or indirect effects on cells (Scott et al., 2002). LL-37 has been shown to block a number 
of LPS-induced inflammatory responses, including contractility and (nitric oxide) NO 
release in aortic rings (Ciornei et al., 2003), pro-inflammatory cytokine production in a 
macrophage cell line and in animal models (Scott et al., 2000; Ohgami et al., 2003), 
suppression of leukocyte infiltration in a model of endotoxin-induced uveitis (Ohgami et al., 
2003) and lethality in animal models of sepsis (Scott et al., 2002).  These effects occur at 
concentrations in the physiological range for LL-37 (1–5 μg/ml) and may reflect a natural 
role for LL-37 in the body (e.g. balancing of the potential stimulus by endotoxin from 
commensals). This anti-endotoxin activity appears to correlate with an ability to dampen the 
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pro-inflammatory effects of the Gram-positive surface molecule lipoteichoic acid (Scott et 
al., 2002; Gutsmann et al., 2010) designed a new class of peptides synthetic anti-LPS peptides 
(SALPs). SALPs were originally based on the LPS-binding domain of the Limulus anti-LPS 
factor (LALF) but were substantially changed in length and primary sequence for optimal 
binding to the lipid A portion of LPS. They observed that these peptides are highly efficient 
in neutralization of LPS and blockage of its immunopathological consequences in vitro and 
in vivo. SALPs combine excellent selectivity for LPS, with high neutralizing activity in vitro 
and potent protection to septic shock using the murine model in vivo. They also demonstrate 
the biological efficacy of rationally designed new synthetic antilipopolysaccharide peptides 
(SALPs) based on the Limulus anti-LPS factor for systemic application. Efficient inhibition of 
LPS-induced cytokine release and protection from lethal septic shock in vivo was analyzed, 
whereas cytotoxicity was not observed under physiologically relevant conditions and 
concentrations. It seems that the lipid A part of LPS is converted from its “endotoxic 
conformation,” the cubic aggregate structure, into an inactive multilamellar structure. These 
observations suggest a novel therapeutic role of AMPs. 
4.3 Anti-viral activity 
Apart from the antibacterial activity, AMPs also possess antiviral activity.  For example, the 
α-defensins target the human immunodeficiency virus (HIV) activity by directly 
inactivating viral particles and affecting the ability of the virus to replicate within CD4 cells. 
Human α-defensins HNP-1 to -3 and HD-5 have been shown to block papillomavirus 
infection. Retrocyclin 2, a synthetic θ-defensin peptide that humans do not synthesize due to 
a mutation in the corresponding human gene, has the capacity to block influenza virus 
infection. Human β-defensins can also block HIV-1 replication, and interestingly, a single 
nucleotide polymorphism in a β-defensin gene has been associated with clinical 
manifestation of HIV-1 infection, suggesting that the human β-defensins play an important 
role in host defense against HIV. Cathelicidins, in contrast, have an inhibitory effect on 
lentiviral replication in vitro, and LL-37 appears capable of interfering with vaccinia virus 
replication in vitro and in mice. Dermaseptin S4, a 28-residue AMP isolated from frog skin, 
attenuates HIV infection in vitro. Other AMPs from frog skin including caerin 1.1, caerin 1.9, 
and maculatin 1.1 have also demonstrated inhibition of HIV in vitro(Albiol Matanic and 
Castilla, 2004).(Daher et al., 1986; Sinha et al., 2003; Yasin et al., 2004). Our group has worked 
with the peptide named scorpine from the venom of Pandinus imperator scorpion, where we 
observed a very interesting anti-virus dengue and anti-plasmodium activity (Carballar-
Lejarazu et al., 2008). Scorpine is an antimicrobial peptide whose structure resembles a hybrid 
between a defensin and a cecropin. It exhibits antibacterial activity and inhibits the sporogonic 
development of parasites responsible for murine malaria. The recombinant expressed scorpine 
(RScp) in Anopheles gambie cells showed antibacterial activity against Bacillus subtilis and 
Klebsiella pneumoniae, at 5 and 10 µM, respectively. It also produced 98%mortality in sexual 
stages of Plasmodium berghei at 15 µM and 100% reduction in Plasmodium falciparum parasitemia 
at 5 µM. RScp also inhibited virus dengue-2 replication in C6/36 mosquito cells. In addition, 
we generated viable and fertile transgenic Drosophila that over-expresses and correctly secretes 
RScp into the insect hemolymph, suggesting that the generation of transgenic mosquitoes 
resistant to different pathogens may be viable. However, there is no knowledge of their 
mechanics, action. It is necessary to extend these studies with other peptides during infection 
induced with virus dengue and other pathogens.   
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5. Evolutionary perspective on antimicrobial peptides 
In this chapter, we proposed a structural classification of antimicrobial peptide families 
considering the diversity of their structures and then we reviewed the traditional function 
and biological activities. Finally, we propose new insights into the functions of antimicrobial 
peptides that could provide a large body of research to create new classes of antimicrobial 
therapeutics. AMPs are widespread molecules throughout the animal and plant taxa, this 
fact suggest its relevance in the evolution of immune response. Traditionally, their basic 
molecular and biochemical nature is related to the disruption of membrane potential and/or 
structure with the ensuing cell death. However, the diversity in the structure and biological 
properties (above mentioned) of AMPs within and between species suggest that these 
molecules have different functions in immune response. 
The immune system of living organisms is formed by a set of cells, molecules and reactions. 
All of these features are continuously evolving to resist (attack and eliminate) pathogen 
invasion and to limit the negative (in terms of host survival and reproduction, i.e. fitness) 
consequences of the infection (Hoffmann and Reichhart, 2002). On the other hand, 
pathogens success depends upon overcoming the selective immune pressures brought about 
by the host. As a consequence, both, host and pathogens, evolve traits and strategies to 
increase the fitness of each one. Van Valen (Van Valen, 1973) proposed this co-evolutionary 
arm races as an evolutionary theory called “The Red Queen Hypothesis”. The theory was 
proposed citing Lewis Carrol’s Red Queen, where it takes all the running somebody can do 
to keep in the same place. Given this situation, immunologically, there is never a “best” 
solution to pathogens infection. To understand this scenario, we must consider (1) 
pathogen’s short generational cycles, that may provide enough time to adapt to the host’s 
immune response. As an outcome there will be grounds for high variability in immune 
response. (2) Differences in the kind and burden of pathogens, where divergent host-
pathogen interactions for each species are possible and can be reflected in the course of 
action of taxa immune response (Read and Taylor, 2001). (3) Virulence differences, where 
there can or cannot be a harm imposed on a host (for example Bacillus anthracis vs. 
commensal microbiota). As long Hypothesis, an immune effecter that has the ability to be 
produced under different infection circumstances could have a selective advantage, 
antimicrobial peptides could have this property, as the host has to deal with the problem of 
maximizing fitness under the Red Queen pressure. 
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